Pliant Therapeutics Statistics
NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.5951-0.0249 (-4.02%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Pliant Therapeutics by the numbers
Pliant Therapeutics has a market capitalization of $36.9 million based on 61.99M shares outstanding. With trailing EPS of $-1.46, Pliant Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.6% below its 50-day average and 47.1% below its 200-day average.
Average daily trading volume is 408.93K shares, or about $243,354 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PLRX valuation vs. peer median
| Metric | PLRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $36.89M | $36.44M | +1% |
| Avg. volume | 408.93K | 193.59K | +111% |
Peer median across 8 companies: SDEV, GRCE, CNTB, CUE, DWTX, VERU, ATNM, TLPH.
Valuation
- Market cap
- $36.89M
- EPS (TTM)
- $-1.46
- Shares outstanding
- 61.99M
Price and trading
- Previous close
- 0.62
- Open
- 0.6001
- Day range
- 0.5719 – 0.6139
- 52-week range
- 0.5719 – 1.67
- 52-week change
- -61.61%
- 50-day moving average
- 0.9246
- Beta
- —
- Volume
- 933.40K
- Average volume
- 408.93K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 36.89M
- Forward Pe
- -0.43
- Eps
- -1.46
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.67
- Week52 Low
- 0.57
- Avg Volume
- 408.93K
- Shares Outstanding
- 61.99M
- Ma50
- 0.92
- Ma200
- 1.12
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -64.37%
- Pct From52w Low
- 4.06%